Presentation is loading. Please wait.

Presentation is loading. Please wait.

Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)

Similar presentations


Presentation on theme: "Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)"— Presentation transcript:

1 Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)

2 Background. Surgical atrial ablation procedure (MAZE) may restore sinus rhythm (SR) in pts with atrial fibrillation (AF) undergoing cardiac surgery. Hypothesis (formulated by cardiac surgeons): (1)MAZE restores SR after surgery (2)without increasing perioperative complications (3)SR presence may improve long term outcomes.

3 Methods Prospective randomized open multicenter study Primary efficacy outcome: SR presence (without any AF episode) during 24-hours ECG after 1 year. Primary safety outcome at 30 days: death / myocardial infarction / stroke / renal failure. Main secondary outcome: composite of death, major bleeding, stroke or hospitalization for heart failure after 1 and 5 years.

4 Patients Inclusion criteria: Heart team indication for cardiac surgery AF documented at least twice in last six months - paroxysmal or (long standing) persistent signed informed consent age over 18 years. Exclusion criteria: Emergent surgery 224 pts with AF scheduled for valvular and/or coronary surgery MAZE group (left atrial surgical ablation, n=117) Non-MAZE group (no ablation, n=107)

5 Baseline characteristic n (%)MAZE (n = 117)Non-MAZE (n = 107) Age (years)69.9 ± ± 7.9 Paroxysmal AF26 (22.2)33 (30.8) Persistent AF30 (25.6)25 (23.4) Longstanding persistent AF61 (52.1)49 (45.8) Atrial fibrillation just prior surgery91 (77.8)70 (65.4) Left atrial diameter (mm)48.7 ± ± 7.1 Mean NYHA functional class2.3 ± ± 0.7 Prior stroke / TIA13 (11.1)15 (14.0) Diabetes41 (35.0)40 (37.4) Prior major bleeding4 (3.4)6 (5.6) Ejection fraction (%)52.6 ± ± 12.5 Logistic EuroSCORE5.8 ( )6.8 ( )

6 Surgical procedure Cryomaze (ATS) in 97% pts, radiofrequency in 3% pts. Ablation time for each lesion 90 seconds. Lesion set: pulmonary veins ablation, left atrial appendage exclusion and three interconnecting lesions Epicardially or endocardially (based on whether LA is opened during the main surgical procedure)

7 Procedure types (all-comers with AF)

8 Sinus rhythm after 1 year (primary efficacy end-point, Holter 24-hour ECG) p = 0,002 p = p = 0,194 p< 0,001

9 Evolution of sinus rhytm during 1 year (12-lead ECGs)

10 Perioperative complications Primary safety outcome (death / myocardial infarction / stroke / renal failure at 30 days) p = 0,411

11 Long-term adverse events (Death/ major bleeding/ stroke/ hospitalization for heart failure after 1 year) p = 0,785 p = 0,800 p = 0,654 p = 0,319 p = 0,680

12 Secondary outcomes at 1 year p=0,825 p=0,887 p=0,174

13 Conclusions (1) Surgical ablation improves the likelihood of SR presence up to 1 year postoperatively (2) Without perioperative complications (3) No impact on 1-year clinical outcomes Most significant rhythm benefit in pts with longstanding persistent AF (no benefit seen in paroxysmal AF).


Download ppt "Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)"

Similar presentations


Ads by Google